anidulafungin has been researched along with Health Care Associated Infection in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abastabar, M; Alastruey-Izquierdo, A; Hedayati, MT; Meletiadis, J; Nouripour-Sisakht, S; Rivero-Menendez, O; Sabino, R; Seyedmousavi, S; Siopi, M; Tavakoli, M; Valadan, R; van der Lee, H; Yazdani Charati, J; Zarrinfar, H | 1 |
| Chan, TS; Chim, CS; Gill, H; Hwang, YY; Khong, PL; Kwong, YL; Leung, AY; Lie, AK; Loong, F; Sim, J; Tse, AC; Tse, E | 1 |
| Cattel, F; Corcione, S; D'Avolio, A; De Rosa, FG; Di Perri, G; Motta, I | 1 |
| Carbajal, WH; Lozada, C; Reyes, HA; Valdez, LM | 1 |
| Calvo, B; Colombo, AL; Francisco, EC; Hagen, F; Hernandez, M; Meis, JF; Melo, AS; Perozo-Mena, A | 1 |
| Borges Sá, M; Garnacho Montero, J | 1 |
| De Bellis, P | 1 |
| De Rosa, FG; Falcone, M; Ghezzi, MC; Pasero, D; Raponi, G; Russo, A; Toma, L; Venditti, M | 1 |
| Bennett, JE | 1 |
3 review(s) available for anidulafungin and Health Care Associated Infection
| Article | Year |
|---|---|
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Europe; Fluconazole; Guidelines as Topic; Humans; Italy; Randomized Controlled Trials as Topic; Treatment Outcome; United States | 2014 |
[Role of anidulafungin in critically ill patients].
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Illness; Cross Infection; Drug Therapy, Combination; Echinocandins; Fluconazole; Fungemia; Humans; Immunocompetence; Intensive Care Units; Itraconazole; Practice Guidelines as Topic | 2008 |
Echinocandins for candidemia in adults without neutropenia.
Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fungemia; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Peptides, Cyclic; Practice Guidelines as Topic | 2006 |
6 other study(ies) available for anidulafungin and Health Care Associated Infection
| Article | Year |
|---|---|
Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Aspergillus nidulans; Azoles; Cross Infection; Environmental Microbiology; Genetic Variation; Greece; Humans; Iran; Micafungin; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Epidemiology; Netherlands; Phylogeny; Phylogeography; Portugal; Spain; Tubulin | 2020 |
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients.
Topics: Adenine Nucleotides; Adult; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Arabinonucleosides; Candida; Candidiasis, Invasive; Caspofungin; China; Clofarabine; Cohort Studies; Cross Infection; Echinocandins; Fusariosis; Fusarium; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lipopeptides; Lung Diseases, Fungal; Micafungin; Retrospective Studies; Risk Factors | 2014 |
Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient.
Topics: Adult; Anidulafungin; Antifungal Agents; Aorta; Candida; Candidiasis; Cross Infection; Echinocandins; Echocardiography; Endocarditis; Female; Humans; Immunocompromised Host; Ovarian Neoplasms; Voriconazole | 2015 |
First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia.
Topics: Adult; Aged; Americas; Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Anidulafungin; Antifungal Agents; Azoles; Candida; Candidemia; Cross Infection; Disease Outbreaks; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Venezuela; Young Adult | 2016 |
Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections.
Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candidiasis; Cross Infection; Echinocandins; Humans | 2009 |
Clinical experience of anidulafungin for the treatment of patients with documented candidemia.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Catheters, Indwelling; Cross Infection; Echinocandins; Female; Fluconazole; Humans; Italy; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |